SCHEMBL6781995

SCHEMBL6781995

Cc1cccc2c1C(C)(C(=O)O)c1ccccc1-2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
MYC P01106 1/20 0.42
APEX1 P27695 1/20 0.39
PDK2 Q15119 3/20 0.38
NR1H4 Q96RI1 1/20 0.37
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
HTT P42858 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HPGD P15428 2/20 0.36
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15108863 0.83 ALDH1A1 (0.39) THRBTDP1MYCCYP3A4CYP2C9
SCHEMBL393095 0.83 THRB (0.59) THRBTDP1APEX1PDK2ALDH1A1
Bromide SCHEMBL27743787 0.81 THRB (0.57) THRBTDP1APEX1PDK2ALDH1A1
Bromomethane SCHEMBL209152 0.80 THRB (0.55) THRBTDP1APEX1PDK2ALDH1A1
SCHEMBL8094339 0.79 THRB (0.67) THRBTDP1MYCAPEX1PDK2
SCHEMBL6786858 0.76 ALOX5 (0.38) THRBTDP1MYCHTTHDAC4
SCHEMBL24933869 0.74 PDK2 (0.41) PDK2CYP1A2CYP3A4CYP2C9CYP2C19
Propanol SCHEMBL27824438 0.72 THRB (0.47) THRBTDP1APEX1PDK2ALDH1A1
Nonane SCHEMBL27848744 0.72 TDP1 (0.47) THRBTDP1APEX1CYP2C9CYP2C19
SCHEMBL4577246 0.72 PDK2 (0.47) THRBTDP1MYCPDK2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6696462-B2 CYCLOPROPYLTROPINE CARBOXYLATE DERIVATIVES BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-02-24 US disclosed
US-20030207912-A1 Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH. CO. KG (DE) 2003-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030207912-A1 Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions CHRM1, CHRNA1, CHRNB1 THRB 1279/4885TDP1 3079/4885MYC 4225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.